HSA Product

GAVISCON DOUBLE ACTION TABLETS

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

GAVISCON DOUBLE ACTION TABLETS

Dosage Form

TABLET, CHEWABLE

Regulatory Information

Approval Number

SIN14194P

Approval Date

July 17, 2012

Forensic Classification

General Sale List

Drug Type

Therapeutic

Route of Administration

ORAL

Record Created

August 10, 2023

Last Updated

June 3, 2025

ATC Business ID

XA02BX13

Company Information

ManufacturerRECKITT BENCKISER HEALTHCARE (UK) LIMITED

Registrant

RECKITT BENCKISER (SINGAPORE) PTE LTD

Licence Holder

RECKITT BENCKISER (SINGAPORE) PTE LTD

Active Ingredients

CALCIUM CARBONATE

Strength: 187.5MG

SODIUM BICARBONATE

Strength: 106.5MG

SODIUM ALGINATE

Strength: 250MG

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy